Histopathology of Coronary Artery Chronic Total Occlusions and Its Relevance to Percutaneous Recanalization

Mariem A Sawan1, Rebecca Steinberg1, Aloke V Finn2

  • 1Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA.

PubMed

Insights

Coronary chronic total occlusions (CTOs) are complex, dynamic lesions. Understanding their histopathology, including calcification and fibrosis, is crucial for successful percutaneous coronary intervention.

Area of Science:

  • Interventional Cardiology
  • Pathology

Background:

  • Coronary chronic total occlusions (CTOs) are defined as complete coronary artery obstructions with TIMI 0 flow for 3 months or more.
  • CTOs represent a highly challenging subset of lesions in interventional cardiology.

Purpose of the Study:

  • To elucidate the histopathological characteristics of CTOs.
  • To understand the dynamic and evolving nature of CTOs.
  • To correlate histopathologic insights with percutaneous coronary intervention techniques.

Main Methods:

  • Histopathological analysis of CTO lesions.
  • Examination of lesion composition, including thrombosis, inflammation, neovascularization, fibrosis, and calcification.
  • Assessment of calcification distribution, vessel layer composition, and tissue fiber orientation.

Main Results:

  • CTOs are not static but dynamic, evolving entities.
  • Lesion composition involves a complex interplay of thrombosis, inflammation, neovascularization, fibrosis, and calcification.
  • Specific features like calcification distribution and fiber orientation are key.

Conclusions:

  • Pathologic insights into CTOs are fundamental for modern percutaneous coronary intervention.
  • Understanding the dynamic nature and composition of CTOs improves treatment strategies.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
329
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
348